Ohio Lottery player in Summit County hits jackpot multiple times in same drawing
Odds are you have never won a single Ohio Lottery drawing.
But someone in Summit County has recently won not just one lottery jackpot but nine.
That's right nine. And all in the same drawing.
The Ohio Lottery says a single winner won $225,000 recently playing the Pick 5 lotto drawing.
The winner, whose name was not released, purchased nine tickets and won $25,000 on each ticket.
After state and federal tax totaling some 28%, lottery officials say the winner will end up with about $162,000.
The winning tickets were purchased at the Speedway on East Highland Road in Macedonia.
Pick 5 has daily drawings at 12:29 p.m. and 7:29 p.m. seven days a week.
The odds of winning the $25,000 jackpot with a 50 cent wager and correctly picking the five numbers in order are one in 100,000,
This article originally appeared on Akron Beacon Journal: You won't believe the luck of a Summit County Ohio Lottery player
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
Next phase builds on 34+ years of serving the needs of US patients and healthcare providers COLUMBUS, Ohio, June 28, 2025 /PRNewswire/ -- In its ongoing mission to help meet America's growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines Manufactured in the USA – will further expand Hikma's well-established domestic capabilities to develop, produce and deliver a broad range of medicines needed by the US healthcare system to treat patients nationwide. Hikma has operated in the US since 1991 and has spent more than $4 billion over the past 15 years to build, enhance and expand its US-based R&D and manufacturing capabilities and now has annual domestic capacity to produce more than 12 billion finished doses of essential medicines. Over this period, Hikma has provided patients with access to a wide range of generic medicines at a lower cost than branded products. The company has an excellent record of US FDA quality inspections and has a successful record of working with FDA to solve critical drug shortages. Elected officials including US Rep. Mike Carey (OH-15) and US Rep. Buddy Carter (GA-01) joined Hikma at a special groundbreaking event held at the Company's state-of-the-art pharmaceutical manufacturing and R&D facility in Columbus, Ohio. America Leans on Hikma represents the Company's latest efforts to increase the volume of essential medicines it develops and produces across its R&D and manufacturing sites in Columbus and Cleveland, Ohio and in Cherry Hill and Dayton, New Jersey. This next phase of expansion will help to strengthen Hikma's portfolio of more than 800 medicines and increase the Company's US-based capacity to produce large volumes of high-quality and affordable medicines for American hospitals, providers and patients. "We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients," said Dr. Hafrun Fridriksdottir, President, Hikma Rx. "Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines." Dr. Bill Larkins, President, Hikma Injectables added, "Over the past 15 years Hikma has grown to become a top three US supplier of sterile injectable medicines by volume with more than 180 injectable products in our portfolio and a growing pipeline. This new phase of US investment will enhance and expand our sterile injectables production capabilities and enable us to continue providing our broad portfolio of essential medicines to US patients." "As a pharmacist and Chairman of the American-Made Medicines Caucus, I understand the crucial role Hikma and other generic manufacturers play in delivering affordable and accessible medicines to Americans. It's important that we onshore the production of these critical drugs. I will continue working with Hikma to strengthen our national security and public health by making life-saving generic medications here, in America, and applaud them for their announcement today," said Rep. Buddy Carter. "Hikma continues to invest in American workers and I am thrilled that they have chosen to continue that commitment here in Columbus. This development will support a critical industry and create more jobs for working families in central Ohio. Additional manufacturing capacity will increase Americans' access to high-quality, affordable medicines. I am proud to join Hikma here today to support their mission and the Ohioans they employ. I look forward to returning to see the new facility once it is complete," Rep. Carey said. Hikma remains steadfast in its mission to provide affordable and accessible health care solutions. With this continued investment, Hikma reaffirms its commitment to ensuring a reliable supply of essential medications for all Americans. Contacts : Hikma Pharmaceuticals PLC Investors Susan Ringdal EVP, Strategic Planning and Global Affairs +44 (0)20 7399 2760/ +44 7776 477050 Media Steven Weiss US Communications +1 732 788 8279 About Hikma(LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated BBB/stable S&P and BBB/stable Fitch) Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across North America, the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 9,500 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: View original content to download multimedia: SOURCE Hikma Pharmaceuticals USA Inc.
Yahoo
5 hours ago
- Yahoo
Mega Millions winning numbers for June 27: Jackpot rises to $348 million
The Mega Millions jackpot rose to $348 million for the drawing on Friday, June 27 after no one matched all the winning numbers in the drawing on Tuesday, June 24. If someone matches all six numbers on Friday, they will have the option of a one-time cash payment of $155.5 million. There have been three Mega Millions winners this year, with the most recent being the April 18 win in Ohio of a $112 million jackpot. Before then, a lucky lottery ticket holder in Illinois took home a $344 million jackpot on March 25, while another lucky person hit the Mega Millions jackpot on Jan. 17 for $113 million. Here are the winning numbers from the Mega Millions drawing on Friday, June 27, 2025. The winning numbers for Friday, June 27: 18-21-29-42-50, Mega Ball: 02 Winning lottery numbers are sponsored by Jackpocket, the official digital lottery courier of the USA TODAY Network. A lucky Mega Millions player in Virginia matched all the numbers and the Mega Ball to win the $348 million jackpot ($155.5 million cash option). The jackpot now resets to $50 million, with a cash option of $22.4 million. To view the list of past winners, visit the Mega Millions website. To play the Mega Millions, you have to buy a ticket. You can do this at a variety of locations, including your local convenience store, gas station or even grocery store. In some states, Mega Millions tickets can be bought online. Once you have your ticket, you need to pick six numbers. Five of them will be white balls with numbers from 1 to 70. The gold Mega Ball ranges from 1 to 24. If you're feeling especially unlucky or don't want to go through the hassle of picking, you can ask for a "Quick Pick" or an "Easy Pick.' These options let the computer randomly generate numbers for you. Mega Millions tickets now include a built-in multiplier, which increases non-jackpot prizes by two, three, four, five, or 10 times. Before, players had to pay an extra dollar to add the "Megaplier.' Tickets can be purchased in person at gas stations, convenience stores and grocery stores. Some airport terminals may also sell lottery tickets. You can also order tickets online through Jackpocket, the official digital lottery courier of the USA TODAY Network, in these U.S. states and territories: Arizona, Arkansas, Colorado, Idaho, Maine, Massachusetts, Minnesota, Montana, Nebraska, New Hampshire, New Jersey, New York, Ohio, Oregon, Puerto Rico, Washington, D.C., and West Virginia. The Jackpocket app allows you to pick your lottery game and numbers, place your order, see your ticket and collect your winnings all using your phone or home computer. Jackpocket is the official digital lottery courier of the USA TODAY Network. Gannett may earn revenue for audience referrals to Jackpocket services. Must be 18+, 21+ in AZ and 19+ in NE. Not affiliated with any State Lottery. Gambling Problem? Call 1-877-8-HOPE-NY or text HOPENY (467369) (NY); 1-800-327-5050 (MA); 1-877-MYLIMIT (OR); 1-800-981-0023 (PR); 1-800-GAMBLER (all others). Visit for full terms. Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at and follow him on X @fern_cerv_. This article originally appeared on USA TODAY: Mega Millions winning numbers for 6/27/25: Jackpot at $348 million


Forbes
7 hours ago
- Forbes
The SALT Deduction Isn't Big Enough. We Need A SALT Credit
The wrecked Silver Bridge, spanning the Ohio River between Ohio and West Virginia, pictured after ... More its collapse during rush hour traffic, December 17th 1967. (Photo by) West Virginia must be rich, right? All that federal money that flows there year after year. Hopefully readers see the obvious flaw, or contradiction. Government spending is harmful, by its very description. Precisely because it signals the central planning of market goods, services and labor by politicians, it's economically harmful. Only an economist could believe otherwise. Which requires us to start with first principles of economics that have seemingly been forgotten in the present debate about state and local tax deductions (SALT). Government spending is harmful. Say it repeatedly because economists won't. Take Duke University economist Michael Munger. An individual with a free market bent in good standing with other free market types, Munger writes that 'allowing citizens to deduct state and local taxes effectively rewards high-spending states and punishes prudence.' Munger's assertion is accepted wisdom within, and that's the problem. His views violate basic economic principles. Really, 'high-spending states' are rewarded through SALT deductions? How so? Munger's commentary suggests that states in which local spending and taxation to fund that spending is sizable somehow gain from it. Just once it would be great if Munger or the Rose Bowl size crowd that believes as he does would explain how 'high-spending states' are rewarded when their politicians tax and spend wastefully. Either there's a latent Keynes inside Munger and most free market economists, or they've mistaken the meaning of SALT. Likely both. To understand why, let's say it again: government spending is harmful. California, New York, New Jersey, and Illinois are rich states despite all the local taxing and spending in those states, not because of it. They'd be quite a bit richer if state and local politicians weren't damaging their economies with government spending. It's a long or short way of saying the SALT deduction doesn't reward 'high-spending states' as Munger and the Rose Bowl assume, rather it rewards the U.S. in total by reducing the flow of tax dollars to the federal government. If anything, and assuming Munger et al agree that government spending is harmful, they should clamor for a SALT credit to further limit the federal government's tax share of economic activity in California, New York, and the other high-tax states. See West Virginia if you're confused. Is West Virginia rich or growing because of all the federal monies that have flowed its way for decades and years? Clown question. Central, politicized planning of resources is harmful, always and everywhere. Let's call West Virginia and other poor U.S. states that receive gobs of federal money domestic lab-grown evidence of the truth that just as foreign aid fails always and everywhere around the world, it fails in the U.S. too. Bringing it back to SALT, what Munger et al view as its demerit, that it 'rewards high-spending states and punishes prudence,' is its greatest attribute. As much as possible we want to limit the harmful effects of government waste nationally by limiting the flow of tax dollars from U.S. states. Translated, if California wants to tax and spend imprudently, let it do just that. And let's keep the wealth produced in California from reaching the federal government so that the national government won't have as many dollars to damage the rest of the country with. SALT is simple. It's about putting a fence around big government. Which is why the true aim should be a SALT credit. Anything to localize spending and taxing as much as possible. There's your states as laboratories. If there must be government waste, let it be in cities and states, not from the national government.